Copyright
©The Author(s) 2020.
World J Diabetes. Aug 15, 2020; 11(8): 358-369
Published online Aug 15, 2020. doi: 10.4239/wjd.v11.i8.358
Published online Aug 15, 2020. doi: 10.4239/wjd.v11.i8.358
Table 1 Syringe provision and costs
| Setting | % of settings where syringes are free of charge | Mean (range), range, costs of a syringe to the patient (for systems not providing for free) |
| Public health system | 47.4 | $0.27, $0.04 (Uzbekistan)-$0.97 (Tajikistan) |
| Private retail pharmacy | 0.0 | $0.29, $0.07 (Eritrea)-$1.25 (Bolivia) |
| Public health insurance program | 50.0 | $0.19, $0.10 (Burundi)-$0.28 (Nigeria) |
- Citation: Klatman EL, Ogle GD. Access to insulin delivery devices and glycated haemoglobin in lower-income countries. World J Diabetes 2020; 11(8): 358-369
- URL: https://www.wjgnet.com/1948-9358/full/v11/i8/358.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i8.358